Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02013388 · ClinicalTrials.gov registry record · Phase 1
MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects
A Phase 1 study, sponsored by Nivalis Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
NCT02013388 is a Phase 1 study that has completed, run by Nivalis Therapeutics. The registered enrollment target is 49 participants.
The verdict
NCT02013388, a Phase 1 study, has completed, sponsored by Nivalis Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
A study in healthy subjects to assess the safety, tolerability, and pharmacokinetics of N91115.
Interventions
- DRUG Placebo
- DRUG N91115
- DRUG Placebo-Day 1 only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02013388
The ClinicalTrials.gov registry entry for NCT02013388 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nivalis Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02013388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02013388 about?
NCT02013388 is a clinical study titled "MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects". A study in healthy subjects to assess the safety, tolerability, and pharmacokinetics of N91115.
What is the current status of trial NCT02013388?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2014-02. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02013388?
The interventions under investigation include: Placebo (DRUG), N91115 (DRUG), Placebo-Day 1 only (DRUG).
Who is sponsoring clinical trial NCT02013388?
This trial is sponsored by Nivalis Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.